Regulatory load mounts for European managers
Late last week in London, the current state of hedge fund industry regulation was ably summarised by panellists at The IMS Group Regulatory Forum
Join us and our panel of experts for HFMWeek's Subscribers'…
17/02/2010
Brian DeChristopher, formerly with Putnam Investments, has launched his maiden hedge fund, HFMWeek has learned.
After forming Boston-based Chordant Capital Partners, the Chordant Lifesciences Fund debuted this month. The offering is a long/short global healthcare and life sciences fund with a slight
long-bias. It has 20 long positions and 20-30 shorts. Its capacity is $500m.
DeChristopher, the fund’s portfolio manager and founder, was a healthcare analyst and portfolio manager at Putnam Investments.
Last year, the BarclayHedge healthcare and biotechnology index returned 28% and is down slightly at the start of 2010.
Stocks in the healthcare sector continue to trade at a greater discount to historical premiums. Today healthcare stocks discount to the S&P 500 is around 15% and was trading at an 11% discount
between 2005 and 2008.
The fund has a $250,000 investment minimum, 1.5/15 fees and a one-year lockup. Jefferies & Co and JP Morgan are the prime brokers.
29/02/2012
Join us and our panel of experts for HFMWeek's Subscribers' Club February's UK breakfast briefing…
29/02/2012
The next US HFMWeek Subscribers' Club breakfast, will take place on Wednesday February 29. Join…
02/02/2011
HFMWeek's European Hedge Fund Services Awards are designed to recognise companies that have outperformed...
Be the first to comment on this article!